Analystreport

Kala Pharmaceuticals, Inc. (NASDAQ: KALA) had its price target lowered by analysts at Northland Securities from $6.00 to $4.00.

Kala Pharmaceuticals, Inc.  (KALA) 
Last kala pharmaceuticals, inc. earnings: 2/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.kalarx.com